Clinical Trial Update: Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 study assesses the safety, tolerability, and pharmacokinetics of ascending oral doses of Ingavirin Forte in healthy volunteers, after single and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Respiratory Infection

Drugs mentioned

• Ingavirin Forte

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Influenza, Viral Respiratory Infection | Phase 1 | Status: RECRUITING